Article
Differential splicing, disease and drug targets.
Infectious disorders drug targets - 1 Dec 2008
Villate O, Rastrojo A, López-Díez R, Hernández-Torres F, Aguado B
Abstract excerpt
Genome complexity and diversity can be due to Alternative Splicing (AS), a process by which one gene can generate multiple mRNA isoforms and then several proteins. This is part of a normal process of variation on an individual, and when it is disrupted or modified, may trigger disease. To date, there are many pathologies described due to the effects of altered splicing isoforms, and effort is focused on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
